Check if your research matches the topics covered in Hematology/ Oncology and Stem Cell Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value. Less
Indexed in the following public directories
Overview | |
Publisher | Elsevier |
Language | English |
Publication Time | 27 |
Editorial Review Process | Double blind peer review |
General Details | |
Language | English |
Society/Institute/Sponsor | King Faisal Specialist Hospital & Research Centre |
Website URL | Visit website |
Publication Details | |
Publication Time | 27 |
Editorial Review Detail | |
Information for authors |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
In 2023, Hematology/ Oncology and Stem Cell Therapy publsihed 25 articles.
For Hematology/ Oncology and Stem Cell Therapy, eISSN is 2589-0646 and pISSN is 1658-3876.
Citescore for Hematology/ Oncology and Stem Cell Therapy is 3.
SNIP score for Hematology/ Oncology and Stem Cell Therapy is 1.
SJR for Hematology/ Oncology and Stem Cell Therapy is Q3.
Elsevier is the publisher of Hematology/ Oncology and Stem Cell Therapy.